Introduction {#sec1}
============

Osteoporosis is a systemic skeletal disease characterized by a systemic impairment of bone mass and microarchitecture that results in a high risk of fractures \[[@B1]\]. According to WHO, osteoporosis is the reduction in bone density below 2.5 standard deviation from the average for healthy and mature adults with similar ethnicity and age. It is one of the most common metabolic bone diseases in the world, affecting women over the age of 59 and men over the age of 74 \[[@B2]\]. It was reported that there were approximately 200 million osteoporosis patients in the world \[[@B3]\]. Therefore, it is very important to explore the potential pathogenic factors.

Multiple factors were reported to affect osteoporosis, including environmental factors such as exercise, smoking and alcohol consumption, metabolic syndrome, and genetic factors \[[@B4]\]. Among them, genes were a very important factor. The heritability of osteoporosis-related traits (such as bone mineral density) was reported to be up to 60--80% \[[@B7]\]. Up till now, tens of hundreds of risk genes have been identified for osteoporosis, including collagen type I α 1 gene (COL1A1), calcitonin receptor (CTR), estrogen receptor (ESR), vitamin D receptor (VDR), and so on \[[@B8]\]. Most of these genes are known to influence the reabsorption of bone by osteoclasts and the formation of bone by osteoblasts.

VDR was the most extensively reported, located on chromosome 12q13 \[[@B11]\], through mediating 1,25-dihydroxycholecalciferol (1,25(OH)~2~D~3~) to play a variety of biological effects \[[@B12]\]. In human monocytes, 1,25(OH)~2~D~3~ modulates chromatin accessibility at 8979 loci \[[@B13]\]. Therefore, VDR polymorphisms were associated with a variety of diseases, including bone mineral density and osteoporosis \[[@B14],[@B15]\]. Morrison et al. \[[@B16]\] first investigated that variability in osteocalcin levels reflect allelic variation in the VDR gene. Since then, a large number of studies have reported that VDR gene mutations (such as *FokI* (rs10735810), *BsmI* (rs1544410) and *Cdx2* (rs11568820) were related to osteoporosis risk. However, these results were inconsistent or even conflicting. For example, Ling et al. \[[@B15]\] found that *VDR* Cdx-2 A allele was associated with decreased bone mineral density (BMD) risk and increased fracture risk. On the contrary, A allele was found to have protective effect on osteoporotic fractures in some studies \[[@B14],[@B17]\]. Similarly, they were also conflicting in different studies \[[@B18]\] on the associations between the *VDR* FokI and BsmI polymorphisms and osteoporosis risk. These different results may be caused by small sample size, different races, regions, and sampling methods. Although several related meta-analyses have reported the associations between *VDR* BsmI, FokI, and Cdx2 polymorphisms and the risk of osteoporosis \[[@B24]\]. However, their studies have some disadvantages. First, the results of these meta-analyses were inconsistent. For example, Jia et al. \[[@B27]\] found that the *VDR* BsmI polymorphism may have a protective effect on the development of osteoporosis. However, Gang et al. \[[@B28]\] concluded that there was no association between *VDR* BsmI polymorphism and osteoporosis risk. Second, literature quality assessments had not been performed in some studies \[[@B24],[@B25],[@B27]\]. In addition, they did not evaluate the credibility of statistically significant associations \[[@B24]\]. Furthermore, some new studies have been published on the VDR polymorphisms and osteoporosis risk. Therefore, we performed an updated meta-analysis to provide more reliable results on these issues.

Materials and methods {#sec2}
=====================

Search strategy {#sec2-1}
---------------

We performed the meta-analysis according to the guidelines of the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) group \[[@B30]\]. Databases including PubMed, Embase, and Chinese Wanfang Data Knowledge Service Platform were searched to investigate the association between VDR polymorphisms and osteoporosis risk. The following search strategy were used: (VDR OR vitamin D receptor OR BsmI OR FokI OR Cdx2) AND (polymorphism OR mutaion OR variant) AND (osteoporosis OR osteoporoses). The search deadline was November 2019.

Selection criteria {#sec2-2}
------------------

The inclusion criteria were as follows: (1) case--control or cohort studies; (2) describe the association among *VDR* BsmI, FokI, and Cdx2 polymorphisms and osteoporosis risk; (3) the case and control groups have sufficient genotype data in the selected literature.

The exclusion criteria were: (1) duplicated studies; (2) studies without available data; (3) case reports, reviews, letters, and meta-analyses.

Data extraction {#sec2-3}
---------------

The data extraction tables in the present study were prepared in advance. According to the established inclusion and exclusion criteria, the data were independently extracted and cross-checked; if there was any objection, the consensus can not be reached after discussion and negotiation. The third author was invited to extract the data again, and finally check and confirm. If the data are not detailed or in doubt, try to contact the original author, supplement and confirm the accuracy and integrity of the data. The extracted information was as follows: first author's surname, publication year, country, ethnicity, age of cases and controls, the number of cases and controls, diagnostic criteria for osteoporosis, menopausal status, matching variables, site of BMD measurement, and number of genotype distributions in cases and controls.

Quality assessment {#sec2-4}
------------------

The quality of all eligible studies was independently assessed by the two authors. We designed quality assessment criteria on the basis of two previous meta-analyses \[[@B31],[@B32]\]. Supplementary Table S1 lists the scale for quality assessment of molecular association studies of osteoporosis risk. The total score was 20 points, studies scoring above 12 were excellent, those scoring less than 9 were poor, and those scoring between 9 and 12 were moderate.

Statistical analysis {#sec2-5}
--------------------

The odds ratios (ORs) and 95% confidence intervals (95% CIs) were pooled to evaluate the association strength, *P*\<0.05 was considered as statistically significant. Five genetic model comparisons were used: (1) allele model; (2) additive model; (3) dominant model; (4) recessive model; (5) overdominant model. Heterogeneity test used Chi-square-based Q-test and *I^2^* test. There was no obvious heterogeneity among studies when *P*\>0.10 and/or *I^2^* ≤ 50% \[[@B33]\] and the ORs were pooled to apply a fixed-effects model \[[@B34]\]. Otherwise, a random-effects model was selected \[[@B35]\]. Furthermore, a meta-regression analysis was applied to explore sources of heterogeneity. Subgroup analyses were performed according to ethnicity or gender. Sensitivity analysis was estimated by the following three methods: (1) a single study was removed each time; (2) exclude low quality and Hardy--Weinberg Disequilibrium (HWD) studies; (3) the studies met the following conditions: high-quality studies, Hardy--Weinberg Equilibrium (HWE), and matching studies. Chi-square goodness-of-fit test was applied to examine HWE, and it was considered as HWE in control groups if *P*\>0.05. In addition, the false-positive report probabilities (FPRP) test \[[@B36]\] and the Venice criteria \[[@B37]\] were applied to assess the credibility of statistically significant associations. Begg's funnel plot \[[@B38]\] and Egger's test were used to evaluate the publication bias \[[@B39]\]. All statistical analyses were conducted using Stata 12.0 software.

Results {#sec3}
=======

Description of included studies {#sec3-1}
-------------------------------

We got 506 articles by searching, according to the inclusion and exclusion criteria, 43 studies met our requirements (involving 4680 osteoporosis cases and 5373 controls) \[[@B21],[@B22],[@B40]\], of which 34 studies explored the association between *VDR* BsmI and osteoporosis risk (involving 2973 osteoporosis cases and 3724 controls), 19 studies reported *VDR* FokI (involving 3694 osteoporosis cases and 2943 controls), and 4 studies explored *VDR* Cdx2 (involving 378 osteoporosis cases and 743 controls). In addition, 23, 11, 4, 3, 1, and 1 case--control studies were conducted to analyze Caucasians, East Asians, West Asians, Indians, Southeast Asians, and Africans, respectively. Among them, seven studies were performed to examine the association between men and osteoporosis risk, and 38 studies explored the association between women and osteoporosis risk. Thirty studies on postmenopausal women, two studies on premenopausal women, and nine studies did not describe menopause status. Finally, there were 9 high-quality studies, 20 medium-quality studies, and 5 low-quality studies on *VDR* BsmI; 7 high-quality studies, 10 medium-quality studies, and 2 low-quality studies on *VDR* FokI; and 3 medium-quality studies and 1 low-quality study on *VDR* Cdx2. The detailed characteristics and scoring of each study are displayed in [Table 1](#T1){ref-type="table"}. The literature selection and inclusion processes are shown in [Figure 1](#F1){ref-type="fig"}. The genotype frequencies of *VDR* BsmI, FokI, and Cdx2 polymorphisms with osteoporosis risk and HWE test results were shown in [Tables 2--4](#T2 T3 T4){ref-type="table"}.

![Flow diagram of the literature search](bsr-40-bsr20201200-g1){#F1}

###### Main characteristics and quality score of studies included

  First author/year        Country     Ethnicity         Gender      Cases   Controls        Score                                                                                               
  ------------------------ ----------- ----------------- ----------- ------- --------------- ------- ----------- ---------------- ------------- ----- ----- --------------- -------- ----------- ----
  Kow, 2019                British     Caucasian         Men         69      58.96 ± 12.78   Ne      LS-fn       WHO              Age and Sex   121   Yes   64.98 ± 10.06   Ne       LS-hip      15
  Techapatiphandee, 2018   Thai        Southeast Asian   Female      105     73.10 ± 8.90    PSM     LS-hip      WHO              Sex           132   Yes   63.40 ± 8.70    PSM      LS-hip      13
  Ahmad, 2018              India       Indian            Female      254     56.12 ± 7.00    PSM     LS-hip-fn   WHO              Age and Sex   254   Yes   55.11 ± 5.66    PSM      LS-hip      14
  Meng, 2017               China       East Asian        Female      90      67.20 ± 8.60    Ne      LS-hip      Ne               Sex           246   Yes   55.90 ± 9.60    Female   LS-hip      8
  Dehghan, 2016            Iran        West Asian        Men         130     46.10 ± 6.00    Ne      LS-fn       WHO              Sex           70    Yes   46.10 ± 6.00    Men      LS-hip      10
  Ziablitsev, 2015         Ukraine     Caucasian         Female      30      Ne              PSM     Ne          Ne               Sex           44    Yes   Ne              PSM      Ne          8
  Mohammadi, 2015          Iran        West Asian        Female      142     58.10 ± 7.90    PSM     LS-hip-fn   WHO              Age and Sex   31    Yes   58.10 ± 7.90    PSM      LS-hip-fn   14
  Mohammadi, 2015          Iran        West Asian        Female      101     35.40 ± 9.00    Pre     LS-hip-fn   WHO              Age and Sex   374   Yes   35.40 ± 9.00    Pre      LS-hip-fn   15
  Mohammadi, 2015          Iran        West Asian        Men \< 50   75      32.90 ± 8.60    Ne      LS-hip-fn   WHO              Age and Sex   195   Yes   32.90 ± 8.60    Ne       LS-hip-fn   15
  Mohammadi, 2015          Iran        West Asian        Men ≥ 50    112     61.20 ± 8.90    Ne      LS-hip-fn   WHO              Age and Sex   24    Yes   61.20 ± 8.90    Ne       LS-hip-fn   14
  Moran, 2015              Spanish     Caucasian         Female      150     60.24 ± 7.74    PSM     LS-fn       WHO              Age and Sex   30    Yes   59.73 ± 9.28    PSM      LS-fn       16
  Boroń, 2015              Poland      Caucasian         Female      278     Ne              PSM     LS          Ne               Age and Sex   292   Yes   Ne              PSM      LS          13
  Marozik, 2013            Belarus     Caucasian         Female      54      58.30 ± 6.20    PSM     LS-fn       WHO              Age and BMI   77    Yes   56.70 ± 7.40    PSM      LS-fn       11
  González, 2013           Mexico      Caucasian         Female      88      57.65 ± 5.58    PSM     LS-fn       WHO              Sex           88    Yes   56.34 ± 4.98    PSM      LS-fn       11
  Pouresmaeili, 2013       Iran        West Asian        Female      64      53.53 ± 9.80    Ne      LS-fn       WHO              Age and Sex   82    Yes   53.53 ± 9.80    Ne       LS-fn       12
  Efesoy, 2011             Turkey      Caucasian         Female      40      65.75 ± 9.80    PSM     LS-fn       WHO              Sex           30    Yes   62.40 ± 8.70    PSM      LS-fn       11
  Yasovanthi, 2011         India       Indian            Female      247     57.70 ± 4.60    PSM     LS          WHO              Age and Sex   254   Yes   57.70 ± 4.60    PSM      LS          16
  Yasovanthi, 2011         India       Indian            Female      180     39.50 ± 4.40    Pre     LS          WHO              Age and Sex   206   Yes   39.50 ± 4.40    Pre      LS          15
  Xing, 2011               China       East Asian        Female      32      72.50 ± 6.40    Ne      LS          T-score \< 2.0   Sex           70    Yes   70.50 ± 5.20    Female   LS          9
  Mansour, 2010            Egypt       African           Female      50      54.40 ± 5.10    PSM     LS-fn       WHO              Age and Sex   20    Yes   53.50 ± 5.40    PSM      LS-fn       8
  Durusu, 2010             Turkey      Caucasian         Female      50      58.30 ± 6.50    PSM     LS-hip-fn   WHO              Sex           50    Yes   57.30 ± 6.60    PSM      LS-hip-fn   11
  Gu, 2010                 China       East Asian        Female      33      58.40 ± 6.30    PSM     Fn          WHO              Sex           148   Yes   58.40 ± 6.30    PSM      Fn          11
  Gu, 2010                 China       East Asian        Men         8       61.60 ± 7.00    Ne      Fn          WHO              Sex           260   Yes   61.60 ± 7.00    Men      Fn          12
  Mencej, 2009             Slovenia    Caucasian         Female      239     64.50 ± 8.20    PSM     LS-hip-fn   WHO              Sex           228   Yes   61.50 ± 8.30    PSM      LS-hip-fn   12
  Seremak, 2009            Poland      Caucasian         Female      163     64.27 ± 8.72    PSM     LS          WHO              Sex           63    Yes   63.08 ± 7.24    PSM      LS          10
  Uysal, 2008              Turkey      Caucasian         Female      100     Ne              PSM     LS-fn       WHO              Sex           146   Yes   Ne              PSM      LS-fn       12
  Pérez, 2008              Argentina   Caucasian         Female      64      62.70 ± 0.86    PSM     LS-fn       WHO              Sex           68    Yes   59.40 ± 0.85    PSM      LS-fn       14
  Mitra, 2006              India       Indian            Female      119     54.2 ± 3.40     PSM     LS-fn       WHO              Sex           97    Yes   54.20 ± 3.40    PSM      LS-fn       11
  Zhang, 2006              China       East Asian        Men         26      70.5 ± 5.30     Ne      LS          T-score \< 2.0   Sex           66    Yes   73.40 ± 4.30    Men      LS          7
  Liu, 2005                China       East Asian        Men         89      Ne              Ne      LS-hip      T-score \< 2.0   Sex           56    Yes   Ne              Men      LS-hip      10
  Zhu, 2004                China       East Asian        Female      40      Ne              PSM     LS-fn       WHO              Sex           158   Yes   Ne              PSM      LS-fn       10
  Duman, 2004              Turkey      Caucasian         Female      75      53.16 ± 1.31    PSM     LS-hip      WHO              Age and Sex   66    Yes   52.62 ± 1.69    PSM      LS-hip      10
  Lisker, 2003             Mexico      Caucasian         Female      65      65.20 ± 6.80    PSM     LS-fn       WHO              Sex           57    Yes   56.50 ± 6.00    PSM      LS-fn       11
  Douroudis, 2003          Greece      Caucasian         Female      35      61.37 ± 0.96    PSM     Forearm     WHO              Sex           44    Yes   58.68 ± 1.01    PSM      Forearm     12
  Chen, 2003               China       East Asian        Female      78      54.72 ± 2.60    PSM     Forearm     T-Score \< 2.0   Sex           81    Yes   53.68 ± 2.90    PSM      Forearm     9
  Zajickova, 2002          Czech       Caucasian         Female      65      60.10 ± 10.30   PSM     LS-hip      WHO              Sex           33    Yes   63.60 ± 7.80    PSM      LS-hip      10
  Pollak, 2001             Israel      West Asian        Female      75      Ne              Ne      LS-fn       WHO              Sex           143   Yes   Ne              Ne       LS-fn       13
  Langdahl, 2000           Aarhus      Caucasian         Men         30      55.70 ± 11.00   Ne      LS-hip      WHO              Age and Sex   73    Yes   51.10 ± 15.70   Ne       LS-hip      13
  Langdahl, 2000           Aarhus      Caucasian         Female      80      58.20 ± 6.40    Ne      LS-hip      WHO              Age and Sex   80    Yes   56.20 ± 7.70    Ne       LS-hip      13
  Fontova Garrofe, 2000    Spanish     Caucasian         Female      75      58.30 ± 5.00    PSM     LS-hip      WHO              Sex           51    Yes   57.20 ± 4.50    PSM      LS-hip      9
  Choi, 2000               Korea       East Asian        Female      48      55.10 ± 6.00    PSM     LS-fn       WHO              Sex           65    Yes   55.10 ± 6.00    PSM      LS-fn       11
  Zhang, 1998              China       East Asian        Female      17      56\. 76         Ne      LS          Ne               Sex           52    Yes   54.38           Female   LS          6
  Lucotte, 1999            French      Caucasian         Female      124     63.00 ± 12.30   PSM     LS-fn       WHO              Age and Sex   105   Yes   63.00 ± 12.30   PSM      LS-fn       15
  Gennari, 1999            Italian     Caucasian         Female      164     57.70 ± 0.60    PSM     LS          WHO              Sex           119   Yes   56.90 ± 0.60    PSM      LS          12
  Gennari, 1998            Italian     Caucasian         Female      155     58.20 ± 0.60    PSM     LS          WHO              Sex           136   Yes   57.10 ± 0.70    PSM      LS          12
  Vandevyver, 1997         Belgium     Caucasian         Female      698     75.20 ± 4.70    PSM     LS-fn       Ne               Sex           86    Yes   66.30 ± 8.40    PSM      LS-fn       9
  Tamai, 1997              Japan       East Asian        Female      90      71.00 ± 10.00   Ne      LS          Ne               Sex           92    Yes   43.00 ± 17.00   Female   LS          7
  Yanagi, 1996             Japan       East Asian        Female      23      Ne              Ne      LS          Ne               Sex           66    Yes   Ne              Female   LS          7
  Houston, 1996            U.K.        Caucasian         Female      44      66.00 ± 0.85    Ne      LS-hip      WHO              Sex           44    Yes   65.30 ± 0.95    Female   LS-hip      13

Abbreviations: Fn, femoral neck; LS, lumbar spine; N, not available; Pre, premenopause; PSM, postmenopausal.

^1^Mean ± SD years.

###### Genotype frequencies of VDR *BsmI* polymorphism in studies included in this meta-analysis

  First author/year        Ethnicity         Gender   Case   Control   HWE                              
  ------------------------ ----------------- -------- ------ --------- ----- ----- ----- ----- -------- --------
  Kow, 2019                Caucasian         Male     31     66        21    11    34    13    1.752    0.1856
  Techapatiphandee, 2018   Southeast Asian   Female   85     19        1     103   25    4     2.377    0.1231
  Ahmad, 2018              Indian            Female   54     137       63    54    152   48    9.909    0.0016
  Meng, 2017               East Asian        Female   4      12        74    6     24    216   19.383   0
  Dehghan, 2016            West Asian        Male     31     70        29    14    39    17    0.947    0.3304
  Moran, 2015              Caucasian         Female   18     65        67    3     19    8     2.752    0.0972
  Boroń, 2015              Caucasian         Female   101    121       56    128   113   51    8.26     0.0041
  Marozik, 2013            Caucasian         Female   12     31        11    11    26    40    3.495    0.0616
  González-Mercado, 2013   Caucasian         Female   6      28        54    4     38    46    1.234    0.2667
  Pouresmaeili, 2013       West Asian        Female   14     33        17    13    33    36    1.31     0.2524
  Efesoy, 2011             Caucasian         Female   5      23        12    5     15    10    0.024    0.8756
  Mansour, 2010            African           Female   27     15        8     1     2     17    3.951    0.0469
  Mencej-Bedrac, 2009      Caucasian         Female   27     110       103   40    100   88    1.538    0.2149
  Seremak, 2009            Caucasian         Female   27     66        70    10    27    26    0.442    0.5062
  Durusu, 2010             Caucasian         Female   15     19        16    19    7     24    25.717   0
  Uysal, 2008              Caucasian         Female   18     48        34    24    78    44    1.155    0.2826
  Pérez, 2008              Caucasian         Female   17     35        12    20    32    16    0.21     0.6469
  Mitra, 2006              Indian            Female   51     46        22    19    38    40    3.072    0.0796
  Liu, 2005                East Asian        Male     2      11        76    0     6     50    0.179    0.6719
  Zhu, 2004                East Asian        Female   6      26        8     7     105   46    27.257   0
  Duman, 2004              Caucasian         Female   18     54        3     24    72    4     25       0
  Lisker, 2003             Caucasian         Female   15     17        34    13    38    6     7.133    0.0076
  Douroudis, 2003          Caucasian         Female   3      12        20    10    29    5     4.95     0.0261
  Chen, 2003               East Asian        Female   0      13        65    0     12    69    0.518    0.4715
  Zajickova, 2002          Caucasian         Female   21     24        20    10    13    10    1.485    0.223
  Pollak, 2001             West Asian        Female   18     50        32    11    47    42    0.16     0.6896
  Langdahl, 2000           Caucasian         Male     8      16        6     15    28    30    2.893    0.089
  Langdahl, 2000           Caucasian         Female   23     38        19    25    34    21    1.749    0.186
  Fontova, 2000            Caucasian         Female   9      49        17    10    22    19    0.612    0.4341
  Zhang, 1998              East Asian        Female   0      3         14    0     3     49    0.046    0.8304
  Gennari, 1998            Caucasian         Female   40     92        23    11    76    49    6.129    0.0133
  Vandevyver, 1997         Caucasian         Female   12     50        24    127   368   203   3.142    0.0763
  Tamai, 1997              East Asian        Female   5      11        74    3     16    73    2.784    0.0952
  Yanagi, 1996             East Asian        Female   2      7         57    5     7     11    2.767    0.0962
  Houston, 1996            Caucasian         Female   8      19        17    9     19    16    0.571    0.4498

###### Genotype frequencies of VDR *FokI* polymorphism in studies included in this meta-analysis

  First author/year        Ethnicity         Gender   Case   Control   HWE                             
  ------------------------ ----------------- -------- ------ --------- ----- ----- ----- ---- -------- --------
  Techapatiphandee, 2018   Southeast Asian   Female   31     46        28    41    73    18   2.613    0.106
  Ahmad, 2018              Indian            Female   148    92        14    169   80    5    1.637    0.2008
  Mohammadi, 2015          West Asian        Female   80     56        3     11    17    3    0.95     0.3298
  Mohammadi, 2015          West Asian        Female   52     36        8     198   128   30   1.996    0.1577
  Mohammadi, 2015          West Asian        Male     40     26        3     111   73    9    0.476    0.4903
  Mohammadi, 2015          West Asian        Male     64     41        4     12    9     1    0.182    0.6698
  González, 2013           Caucasian         Female   24     45        19    25    48    15   0.974    0.3238
  Yasovanthi, 2011         Indian            Female   104    119       24    122   124   8    12.594   0.0004
  Yasovanthi, 2011         Indian            Female   73     82        25    97    101   8    8.71     0.0032
  Xing, 2011               East Asian        Female   11     14        7     8     35    27   0.443    0.5058
  Mansour, 2010            African           Female   34     9         7     20    0     0    0        0
  Durusu, 2010             Caucasian         Female   27     22        1     29    18    3    0.009    0.9259
  Gu, 2010                 East Asian        Female   6      18        9     40    84    24   3.266    0.0707
  Gu, 2010                 East Asian        Male     2      5         1     76    137   47   1.171    0.2791
  Mencej-Bedrac, 2009      Caucasian         Female   88     108       44    105   97    26   0.249    0.6179
  Pérez, 2008              Caucasian         Female   22     32        10    22    36    10   0.586    0.4438
  Mitra, 2006              Indian            Female   38     42        39    46    33    18   6.444    0.0111
  Zhang, 2006              East Asian        Male     4      13        9     28    28    10   0.458    0.4984
  Lisker, 2003             Caucasian         Female   27     29        9     20    29    8    0.239    0.625
  Zajickova, 2002          Caucasian         Female   26     28        11    7     21    5    2.54     0.111
  Langdahl, 2000           Caucasian         Male     12     13        5     30    34    9    0.018    0.8943
  Langdahl, 2000           Caucasian         Female   28     42        10    34    31    15   2.554    0.11
  Choi, 2000               East Asian        Female   12     23        13    26    33    6    0.961    0.327
  Lucotte, 1999            Caucasian         Female   45     69        10    40    52    13   0.386    0.5346
  Gennari, 1999            Caucasian         Female   60     73        31    53    55    11   0.372    0.542

###### Genotype frequencies of VDR *Cdx2* polymorphism in studies included in this meta-analysis

  First author/year     Ethnicity    Gender   Case   Control   HWE                            
  --------------------- ------------ -------- ------ --------- ----- ----- ----- ---- ------- --------
  Ziablitsev, 2015      Caucasian    Female   16     20        8     2     12    16   0.015   0.9009
  Marozik, 2013         Caucasian    Female   41     13        0     53    24    0    2.624   0.1052
  Gu, 2010              East Asian   Female   12     16        5     38    72    38   0.108   0.7423
  Gu, 2010              East Asian   Male     4      3         1     81    116   63   2.78    0.0955
  Mencej-Bedrac, 2009   Caucasian    Female   155    75        9     172   48    8    3.709   0.0541

Meta-analysis results {#sec3-2}
---------------------

[Table 5](#T5){ref-type="table"} summarizes the assessment of the association between *VDR* BsmI polymorphism and osteoporosis risk. Overall, significantly increased the risk of osteoporosis was not found for *VDR* BsmI polymorphism (*P*\>0.05 in all genetic models). However, subgroup analysis by ethnicity, we observed that the *VDR* b allele genotype increased the osteoporosis risk (OR = 1.36, 95% CI: 1.06--1.74) and bb genotype (additive model: OR = 0.55, 95% CI: 0.33--0.92; recessive model: OR = 0.65, 95% CI: 0.45--0.96) reduced the risk of osteoporosis in the West Asians, as shown in [Figure 2](#F2){ref-type="fig"}.

![VDR BsmI polymorphism and osteoporosis risk in different races\
The forest plots of all selected studies on the association between VDR *BsmI* polymorphism and osteoporosis risk in different races (**A**) allele model; (**B**) additive model; (**C**) recessive model.](bsr-40-bsr20201200-g2){#F2}

###### Pooled estimates of association of VDR *BsmI* polymorphism and osteoporosis risk

  Genetic model   Variable     Test of association   Tests for heterogeneity   Egger's test            
  --------------- ------------ --------------------- ------------------------- -------------- -------- ------
  B vs b          Overall      1.11 (0.94--1.31)     0.22                      \<0.001        77.40%   0.34
                  Caucasian    0.99 (0.83--1.18)     0.87                      \<0.001        70.70%   
                  East Asian   1.06 (0.59--1.91)     0.85                      \<0.001        76.40%   
                  West Asian   1.36 (1.06--1.74)     0.02                      0.49           0.00%    
                  Indian       1.49 (0.53--4.19)     0.45                      \<0.001        95%      
                  Female       1.09 (0.90--1.31)     0.39                      \<0.001        79.60%   
                  Male         1.29 (0.99--1.67)     0.06                      0.75           0.00%    
  bb vs BB        Overall      0.79 (0.57--1.09)     0.15                      \<0.001        70.70%   0.28
                  Caucasian    0.97 (0.68--1.39)     0.88                      \<0.001        65.20%   
                  East Asian   0.77 (0.19--3.08)     0.71                      0.01           72.40%   
                  West Asian   0.55 (0.33--0.92)     0.02                      0.63           0.00%    
                  Indian       0.53 (0.09--3.26)     0.49                      \<0.001        93.70%   
                  Female       0.82 (0.58--1.17)     0.28                      \<0.001        73.60%   
                  Male         0.58 (0.33--1.02)     0.06                      0.79           0.00%    
  Bb+bb vs BB     Overall      0.87 (0.70-1.07)      0.19                      \<0.001        53.00%   0.15
                  Caucasian    1.02 (0.83--1.27)     0.83                      0.06           34.20%   
                  East Asian   0.74 (0.22--2.46)     0.63                      0.02           65.80%   
                  West Asian   0.68 (0.44--1.07)     0.09                      0.82           0.00%    
                  Indian       0.58 (0.19--1.76)     0.34                      \<0.001        88.40%   
                  Female       0.89 (0.70--1.12)     0.32                      \<0.001        57.70%   
                  Male         0.71 (0.45--1.13)     0.15                      0.94           0.00%    
  bb vs BB+Bb     Overall      0.86 (0.67--1.11)     0.24                      \<0.001        76.10%   0.44
                  Caucasian    0.99 (0.72--1.35)     0.94                      \<0.001        75.70%   
                  East Asian   0.96 (0.53--1.75)     0.89                      0.01           66.80%   
                  West Asian   0.65 (0.45--0.96)     0.02                      0.42           0.00%    
                  Indian       0.69 (0.16--2.93)     0.61                      \<0.001        93.40%   
                  Female       0.89 (0.67--1.17)     0.40                      \<0.001        78.30%   
                  Male         0.70 (0.46--1.06)     0.09                      0.53           0.00%    
  BB+bb vs Bb     Overall      0.98 (0.82--1.15)     0.76                      \<0.001        55.20%   0.84
                  Caucasian    0.98 (0.77--1.24)     0.85                      \<0.001        66.60%   
                  East Asian   1.04 (0.68--1.59)     0.87                      0.19           31.50%   
                  West Asian   0.87 (0.61--1.22)     0.41                      0.49           0.00%    
                  Indian       1.19 (0.89--1.61)     0.24                      0.51           0.00%    
                  Female       0.98 (0.82--1.18)     0.86                      \<0.001        59.30%   
                  Male         0.94 (0.65--1.35)     0.74                      0.56           0.00%    

VDR *BsmI*: allele model: B vs b, additive model: bb vs BB, dominant model: Bb + bb vs BB, recessive model: bb vs BB + Bb, overdominance model: BB + bb vs Bb.

At the overall analysis, significantly increased osteoporosis risk was found in *VDR* FokI ff genotype (additive model: OR = 1.49, 95% CI: 1.07--2.07; recessive model: OR = 1.47, 95% CI: 1.13--1.93). In addition, when stratified by ethnicity, the results showed that f allele and ff genotypes were significantly associated with risk of osteoporosis in Indians. We further performed subgroup analysis according to gender, significantly elevated osteoporosis risk was also observed in ff genotype. All the data are shown in [Table 6](#T6){ref-type="table"}, [Figures 3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}.

![VDR FokI polymorphism and osteoporosis risk in different races\
The forest plots of all selected studies on the association between VDR *FokI* polymorphism and osteoporosis risk in different races (**A**) allele model; (**B**) additive model; (**C**) dominant model; (**D**) recessive model.](bsr-40-bsr20201200-g3){#F3}

![VDR FokI polymorphism and osteoporosis risk between different gender\
The forest plots of all selected studies on the association between VDR *FokI* polymorphism and osteoporosis risk between different gender (**A**) additive model; (**B**) recessive model.](bsr-40-bsr20201200-g4){#F4}

###### Pooled estimates of association of VDR *FokI* polymorphism and osteoporosis risk

  Genetic model   Variable     Test of association   Tests for heterogeneity   Egger's test            
  --------------- ------------ --------------------- ------------------------- -------------- -------- ------
  F vs f          Overall      0.86 (0.74--0.98)     0.03                      \<0.001        55.80%   0.30
                  Caucasian    0.89 (0.77--1.03)     0.12                      0.35           9.70%    
                  East Asian   0.78 (0.42--1.45)     0.43                      0.001          79.10%   
                  West Asian   1.18 (0.85--1.63)     0.32                      0.002          73.90%   
                  Indian       0.68 (0.58--0.80)     0                         0.63           0.00%    
                  Female       0.86 (0.74--1.00)     0.05                      \<0.001        59.90%   
                  Male         0.83 (0.56--1.23)     0.35                      0.14           41.90%   
  ff vs FF        Overall      1.49 (1.07--2.07)     0.02                      \<0.001        57.10%   0.11
                  Caucasian    1.23 (0.87--1.73)     0.24                      0.26           19.50%   
                  East Asian   1.69 (0.44--6.58)     0.45                      0.001          79.30%   
                  West Asian   0.66 (0.29--1.54)     0.34                      0.23           31.10%   
                  Indian       3.25 (2.14--4.94)     0                         0.87           0.00%    
                  Female       1.46 (1.02--2.11)     0.04                      \<0.001        62.60%   
                  Male         1.61 (0.71--3.66)     0.25                      0.27           22.70%   
  Ff+ff vs FF     Overall      1.16 (0.98--1.37)     0.08                      0.02           40.00%   0.42
                  Caucasian    1.16 (0.96--1.40)     0.12                      0.45           0.00%    
                  East Asian   1.33 (0.53--3.35)     0.55                      0.01           73.00%   
                  West Asian   0.85 (0.58--1.24)     0.40                      0.23           30.70%   
                  Indian       1.40 (1.14--1.71)     0.001                     0.64           0.00%    
                  Female       1.15 (0.96--1.38)     0.12                      0.02           45.20%   
                  Male         1.19 (0.74--1.90)     0.47                      0.26           24.10%   
  ff vs FF+Ff     Overall      1.47 (1.13--1.93)     0.01                      0.01           47.50%   0.13
                  Caucasian    1.21 (0.89--1.64)     0.24                      0.28           17.70%   
                  East Asian   1.55 (0.67--3.60)     0.31                      0.02           64.70%   
                  West Asian   0.77 (0.42--1.43)     0.41                      0.41           0.00%    
                  Indian       2.87 (1.93--4.26)     0                         0.67           0.00%    
                  Female       1.48 (1.09--2.00)     0.01                      0.001          55.40%   
                  Male         1.50 (0.81--2.79)     0.20                      0.55           0.00%    
  FF+ff vs Ff     Overall      1.01 (0.90--1.13)     0.87                      0.69           0.00%    0.96
                  Caucasian    0.97 (0.81--1.18)     0.78                      0.41           3.60%    
                  East Asian   1.02 (0.69--1.51)     0.91                      0.88           0.00%    
                  West Asian   1.06 (0.78--1.45)     0.71                      0.53           0.00%    
                  Indian       0.97 (0.80--1.19)     0.80                      0.63           0.00%    
                  Female       1.03 (0.90--1.15)     0.78                      0.45           0.80%    
                  Male         0.94 (0.65--1.37)     0.76                      0.93           0.00%    

VDR *FokI*: allele model: F vs f, additive model: ff vs FF, dominant model: Ff+ff vs FF, recessive model: ff vs FF+Ff, overdominance model: FF+ff vs Ff.

No significant association was observed between *VDR* Cdx2 polymorphism and osteoporosis risk, as shown in [Table 7](#T7){ref-type="table"}.

###### Pooled estimates of association of VDR *Cdx2* polymorphism and osteoporosis risk

  Genetic model   Test of association   Tests for heterogeneity   Egger's test            
  --------------- --------------------- ------------------------- -------------- -------- ------
  G vs A          1.54 (0.80--2.97)     0.20                      \<0.001        82.40%   0.12
  AA VS GG        0.37 (0.11--1.28)     0.11                      0.02           68.30%   0.29
  GA+AA VS GG     0.64 (0.29--0.39)     0.27                      0.002          75.70%   0.01
  AA VS GG+GA     0.48 (0.22--1.07)     0.07                      0.14           45.70%   0.85
  GG+AA VS GA     0.84 (0.58--1.22)     0.36                      0.28           21.30%   0.12

VDR *Cdx2*: allele model: G vs A, additive model: AA VS GG, dominant model: GA+AA VS GG, recessive model: AA VS GG+GA, overdominance model: GG+AA VS GA.

Heterogeneity and sensitivity analyses {#sec3-3}
--------------------------------------

Heterogeneity was observed in overall and several subgroup analyses. Some potential factors were considered as sources of heterogeneity, such as ethnicity, gender, HWE, and menopausal status. Then, we applied meta-regression analysis to explore sources of heterogeneity. The results suggested that the studies of HWD were source of heterogeneity in overall population (additive model: *P*=0.024). In addition, the studies of HWD was also the source of heterogeneity on the association between women and osteoporosis risk (additive model: *P*=0.029 and recessive model: *P*=0.025).

Sensitivity analysis was estimated by applying three methods in this meta-analysis. First, results did not change when removing a single study each time to appraise the robustness. However, when we excluded studies of low quality and HWD, significantly decreased osteoporosis risk was found in overall analysis for *VDR* BsmI bb genotype (additive model: OR = 0.74, 95% CI: 0.56--0.99; recessive model: OR = 0.79, 95% CI: 0.63--0.98). Further, when we restrained only including high-quality HWE, and matching studies, the corresponding pooled OR do not appear to be significantly affected. Therefore, the results of the sensitivity analysis are shown in [Tables 8](#T8){ref-type="table"} and [9](#T9){ref-type="table"}.

###### Pooled estimates of association of VDR *BsmI, FokI, Cdx2* polymorphism and osteoporosis risk, excluding low quality and HWD studies

  Genetic model   Test of association   Tests for heterogeneity           
  --------------- --------------------- ------------------------- ------- --------
  VDR *BsmI*                                                              
  B vs b          1.16 (1.00--1.35)     0.05                      0.002   53.00%
  bb vs BB        0.74 (0.56--0.99)     0.04                      0.021   42.50%
  Bb+bb vs BB     0.88 (0.72--1.08)     0.22                      0.194   20.60%
  bb vs BB+Bb     0.79 (0.63--0.98)     0.04                      0.004   50.70%
  BB+bb vs Bb     0.91 (0.79--1.06)     0.23                      0.224   17.80%
  VDR *FokI*                                                              
  F vs f          0.93 (0.81--1.08)     0.33                      0.009   48.00%
  ff VS FF        1.17 (0.83--1.66)     0.37                      0.006   50.20%
  Ff+ff VS FF     1.07 (0.89--1.27)     0.47                      0.080   32.60%
  ff VS FF+Ff     1.23 (0.93--1.63)     0.16                      0.036   39.60%
  FF+ff VS Ff     1.01 (0.88--1.15)     0.90                      0.596   0.00%
  VDR *Cdx2*                                                              
  G vs A          1.17 (0.68--2.00)     0.57                      0.026   67.50%
  AA VS GG        0.68 (0.29--1.58)     0.37                      0.269   23.80%
  GA+AA VS GG     0.86 (0.44--1.66)     0.65                      0.030   66.40%
  AA VS GG+GA     0.72 (0.37--1.40)     0.34                      0.531   0.00%
  GG+AA VS GA     0.89 (0.55--1.45)     0.64                      0.166   41.00%

###### Pooled estimates of association of VDR *BsmI, FokI* polymorphism and osteoporosis risk, only studies with high-quality matching, and studies conforming to HWE

  Genetic model   Test of association   Test for heterogeneity           
  --------------- --------------------- ------------------------ ------- --------
  VDR *BsmI*                                                             
  B vs b          1.14 (0.96--1.36)     0.14                     0.469   0.00%
  bb VS BB        0.71 (0.48--1.03)     0.07                     0.652   0.00%
  Bb+bb VS BB     0.86 (0.64--1.14)     0.28                     0.870   0.00%
  bb VS BB+Bb     0.81 (0.61--1.08)     0.15                     0.215   26.80%
  BB+bb VS Bb     0.96 (0.76--1.22)     0.74                     0.410   2.60%
  VDR *FokI*                                                             
  F vs f          0.96 (0.81--1.14)     0.63                     0.157   31.50%
  ff VS FF        1.17 (0.84--1.61)     0.36                     0.120   36.00%
  Ff+ff VS FF     1.08 (0.91--1.30)     0.39                     0.434   0.40%
  ff VS FF+Ff     1.16 (0.86--1.57)     0.35                     0.069   43.30%
  FF+ff VS Ff     0.97 (0.81--1.15)     0.70                     0.301   15.50%

Publication bias {#sec3-4}
----------------

Publication bias was assessed in the overall publication by Begg's funnel plot and Egger's test, the shape of the funnel plots revealed no significant funnel asymmetry ([Figure 5](#F5){ref-type="fig"}) in overall population. The Egger tests also indicated that there was no obvious evidence of publication bias (*P*\>0.05 in all genetic models), as shown in [Tables 5](#T5){ref-type="table"}--[7](#T7){ref-type="table"}.

![Begg's funnel plot to assess publication bias](bsr-40-bsr20201200-g5){#F5}

Credibility of the identified genetic associations {#sec3-5}
--------------------------------------------------

We classified statistically significant associations that met the following criteria as 'positive results' \[[@B81]\]: (1) the *P*-value of Z-test is less than 0.05 in at least two gene models; (2) at the *P*-value level of 0.05, the FPRP is less than 0.2; (3) statistical power \> 0.8; (4) *I^2^* \< 50%. Considered as 'less credible affirmation' with lower threshold when the following conditions were met: (1) *P*-value \<0.05 in at least one of the genetic models; (2) the statistical power was between 50 and 79% or FPRP \> 0.2 or *I^2^* \> 50%. Otherwise, the association was classified as 'null' or 'negative'. After credibility assessment, we identified 'less-credible positive results' for the statistically significant associations in the current meta-analysis. The detailed credibility assessment results are listed in [Table 10](#T10){ref-type="table"}.

###### FPRP values for the statistically significant associations in current meta-analysis

  Variables                             OR (95% CI)         *I^2^* (%)   Statistical power   Prior probability of 0.001           
  ------------------------------------- ------------------- ------------ ------------------- ---------------------------- ------- -------
  Overall                                                                                                                         
  ff vs FF                              1.49 (1.07--2.07)   57.10%       0.098               0.516                        0.994   0.971
  ff vs FF+Ff                           1.47 (1.13--1.93)   47.50%       0.072               0.558                        0.987   0.909
  West Asian                                                                                                                      
  B vs b                                1.36 (1.06--1.74)   0%           0.160               0.782                        0.989   0.949
  bb vs BB                              0.55 (0.33--0.92)   0%           0.057               0.232                        0.998   0.990
  bb vs BB+Bb                           0.65 (0.45--0.96)   0%           0.106               0.449                        0.997   0.985
  Indian                                                                                                                          
  F vs f                                0.68 (0.58--0.80)   0%           0.007               0.594                        0.317   0.006
  ff vs FF                              3.25 (2.14--4.94)   0%           0                   0                            0.957   0.189
  Ff+ff vs FF                           1.40 (1.14--1.71)   0%           0.065               0.75                         0.937   0.565
  ff vs FF+Ff                           2.87 (1.93--4.26)   0%           0                   0.001                        0.957   0.207
  Female                                                                                                                          
  ff vs FF                              1.46 (1.02--2.11)   62.60%       0.148               0.557                        0.997   0.987
  ff vs FF+Ff                           1.48 (1.09--2.00)   55.40%       0.086               0.535                        0.992   0.952
  Exclude low quality and HWD studies                                                                                             
  Overall                                                                                                                         
  bb VS BB                              0.74 (0.56--0.99)   42.50%       0.212               0.759                        0.995   0.982
  bb VS BB+Bb                           0.79 (0.63--0.98)   50.70%       0.314               0.939                        0.99    0.972

Discussion {#sec4}
==========

Osteoporosis is a multifactorial disease and is strongly related to heredity \[[@B7]\]. Genes are very important factors for the risk of osteoporosis. Osteoporosis is characterized by low BMD and microarchitectural deterioration of bone leading to increased bone fragility and a high risk of fracture. The *VDR* gene is considered as a candidate gene and has been widely studied due to it plays a key role in regulating bone resorption and metabolism \[[@B10]\]. And the VDR gene has also been implicated as a factor affecting bone mass \[[@B84]\]. Hence, it will be very important to investigate the association between *VDR* gene polymorphism and osteoporosis. Moreover, the VDR polymorphisms play an important role in the pathogenesis, prevention, diagnosis and treatment of osteoporosis and other disease such as acute ischemic stroke \[[@B85]\]. In addition, single nucleotide polymorphism (SNP) may affect the function of *VDR* and may be related with osteoporosis risk \[[@B82]\]. Although many studies attempted to explore the association between *VDR* polymorphisms and the risk of osteoporosis. However, it is regrettable that no solid evidence has been obtained, which may be due to different reasons, including small sample size, ethnic, and regional differences. In order to overcome these shortcomings, meta-analysis is effective alternative.

A total of six previous meta-analyses explored the association between *VDR* polymorphisms and osteoporosis risk. Wang et al. \[[@B24]\] and Yu et al. \[[@B26]\] explored the association between osteoporosis risk and *VDR* BsmI polymorphism in Chinese and Han Chinese population, respectively. Their results suggested that there was no significant association between *VDR* BsmI polymorphism and osteoporosis risk. In 2013, Jia et al. \[[@B27]\] examined 26 studies including 2274 cases and 3150 controls to show that the *VDR* BsmI polymorphism was associated with an decreased osteoporosis risk. However, the examination of 41 studies on *VDR* BsmI polymorphism (including 3080 cases and 4157 controls) by Gang et al. \[[@B28]\] indicated that the *VDR* BsmI polymorphism was not significantly associated with osteoporosis risk. In addition, the examination of 36 studies on *VDR* BsmI, 15 studies on *VDR* FokI, and three studies on *VDR* Cdx2 by Zhang et al. \[[@B25]\] indicated that the *VDR* BsmI and *VDR* FokI polymorphisms were associated with an increased the risk of developing osteoporosis in overall and Asians, while the *VDR* Cdx2 polymorphism may be not associated with osteoporosis risk. However, *VDR* BsmI and *VDR* FokI polymorphisms had not been found to increase the risk of osteoporosis by Zintzaras et al. \[[@B29]\]. Further, when we examined these meta-analyses carefully, we found some disadvantages. First, quality assessments of the eligible studies had not been performed in some studies \[[@B24],[@B25],[@B27]\], and low-quality literature may be included in these meta-analyses, resulting in deviation of the results. Second, HWE is absolutely necessary for a sound genetic association study. There may be selection bias or genotyping errors if the control group did not meet HWE. It can lead to misleading results. The distribution of genotypes in the control group was not tested by HWE \[[@B24],[@B25]\]. Then, the statistical power was not calculated in some previous meta-analyses \[[@B24],[@B26]\]. Finally, the FPRPs of statistically significant association was not evaluated in all previous meta-analyses \[[@B24]\]. Therefore, results of their meta-analyses may be not credible.

A total of 43 studies were included in the current meta-analysis, of which 34 studies explored the association between *VDR* BsmI and osteoporosis risk, 19 studies reported *VDR* FokI polymorphism, and four studies related to *VDR* Cdx2 polymorphism. Furthermore, five genetic models are compared separately. Overall, compared with the FF and Ff genotypes, statistically significant increased osteoporosis risk was found in the *VDR* FokI ff genotype. In the subgroup analysis, the *VDR* FokI ff genotype was significantly associated with increased osteoporosis risk in Indians and women population. However, significantly decreased the risk of osteoporosis were observed in the West Asians for *VDR* BsmI b allele and bb genotype. In addition, when we excluded studies of low quality and HWD, a significantly decreased the risk of osteoporosis was found in the overall analysis for the *VDR* BsmI bb genotype. Further, significant association did not observed when the pooled analysis was limited only involving high quality, HWE, and matching studies. Furthermore, the current meta-analysis was performed by applying multiple subgroups and different genetic models, at the cost of multiple comparisons, in which case the pooled *P*-value must be adjusted \[[@B83]\]. The Venice criteria, statistical power, and *I*^2^ value were very important criteria \[[@B37]\]. Hence, the FPRP test and Venice criteria were used to assess positive results. After credibility assessment, we identified 'less-credible positive results' for the statistically significant associations in the current meta-analysis. Heterogeneity has also been observed in the current meta-analysis. Results of meta-regression analysis suggested that studies of HWD were the source of heterogeneity. In addition, no obvious asymmetry was found in the study of VDR *BsmI* and *FokI* by the Begg's funnel plots and Egger tests. Due to the limited number of studies, the Begg's funnel plot was not performed to explored publication bias in the VDR *Cdx2* study. Meantime, the Egger tests revealed that there was no clear statistical evidence of publication bias.

The current meta-analysis has the following advantages: (1) the quality of included studies was assessed; (2) the HWE test was performed in the control group; (3) we applied FPRP and Venice criteria to evaluate the significant association in current meta-analysis; (4) the sample size was much larger than the previous meta-analyses; (5) we explored sources of heterogeneity based on meta-regression analysis. However, there are still some limitations in the present study. First, we did not control confounding factors such as smoking, drinking, and variable study designs, were closely related to affect the results. Second, in the subgroup analyses, the number of studies were relatively small in Indians, and there was not enough statistical power to explore the real association. Moreover, due to the limited number of studies, we did not perform subgroup analyses in the pooled analysis of *VDR* Cdx2 polymorphism and osteoporosis risk. Therefore, the study with large sample size and large enough subgroup will help to verify our findings.

In conclusion, these positive findings should be interpreted with caution and indicate that significant association may most likely result from less-credible, rather than from true associations or biological factors on the *VDR* BsmI and FokI polymorphisms with osteoporosis risk*.*
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BMD

:   bone mineral density

FPRP

:   false-positive report probability

HWD

:   Hardy--Weinberg disequilibrium

HWE

:   Hardy--Weinberg equilibrium

LS

:   lumbar spine

OR

:   odds ratio

SNP

:   single nucleotide polymorphism

VDR

:   vitamin D receptor

95% CI

:   95% confidence interval
